RÉSUMÉ
Microglial cell activation is the earliest biomarker of the inflammatory processes that cause central nervous system (CNS) lesions in multiple sclerosis. We hypothesized that 1,25-dihydroxyvitamin D3 (1,25-(OH)2D3) production by activated microglia and macrophages in the CNS inhibits these inflammatory processes. To test this hypothesis, we targeted the Cyp27b1 gene specifically in myeloid cells, then analyzed the influence of disrupted myeloid cell 1,25-(OH)2D3 synthesis on vitamin D3-mediated resistance to experimental autoimmune encephalomyelitis (EAE). Myeloid cell 1,25-(OH)2D3 synthesis was essential for vitamin D3-mediated EAE resistance. Increased CTLA-4 expression in the CNS-infiltrating CD4+ Tconv and Treg cells and decreased splenic B cell CD86 expression correlated with resistance. These new data provide solid support for the view that vitamin D3 reduces MS risk in part through a mechanism involving myeloid cell 1,25-(OH)2D3 production and CTLA-4 upregulation in CNS-infiltrating CD4+ T cells. We suggest that CTLA-4 serves as a vitamin D3-regulated immunological checkpoint in multiple sclerosis prevention.
Sujet(s)
Lymphocytes T CD4+/immunologie , Antigène CTLA-4/analyse , Calcitriol/biosynthèse , Cholécalciférol/pharmacologie , Encéphalomyélite auto-immune expérimentale/prévention et contrôle , Macrophages/métabolisme , Microglie/métabolisme , 25-Hydroxyvitamine D3 1-alpha-hydroxylase/génétique , Animaux , Antigène CD86/analyse , Antigène CTLA-4/physiologie , Modèles animaux de maladie humaine , Femelle , Souris , Sclérose en plaques/prévention et contrôle , Élément de réponse à la vitamine D/physiologieRÉSUMÉ
We investigated how one calcitriol dose plus vitamin D3 reverses experimental autoimmune encephalomyelitis (EAE), a multiple sclerosis model. This protocol rapidly increased CD4+ T cell Ikzf2 transcripts, Helios protein, and CD4+Helios+FoxP3+ T regulatory cells. It also rapidly increased CD4+ T cell Bhmt1 transcripts, betaine:homocysteine methyltransferase-1 (BHMT1) enzyme activity, and global DNA methylation. BHMT1 transmethylates homocysteine to replenish methionine. Targeting the Vdr gene in T cells decreased Ikzf2 and Bhmt1 gene expression, reduced DNA methylation, and elevated systemic homocysteine in mice with EAE. We hypothesize that calcitriol drives a transition from encephalitogenic CD4+ T cell to Treg cell dominance by upregulating Ikzf2 and Bhmt1, recycling homocysteine to methionine, reducing homocysteine toxicity, maintaining DNA methylation, and stabilizing CD4+Helios+FoxP3+Tregulatory cells. Conserved vitamin D-responsive element (VDRE)-type sequences in the Bhmt1 and Ikzf2 promoters, the universal need for methionine in epigenetic regulation, and betaine's protective effects in MTHFR-deficiency suggest similar regulatory mechanisms exist in humans.
Sujet(s)
Lymphocytes T CD4+/effets des médicaments et des substances chimiques , Méthylation de l'ADN/effets des médicaments et des substances chimiques , Encéphalomyélite auto-immune expérimentale/traitement médicamenteux , Méthionine/agonistes , Lymphocytes T régulateurs/effets des médicaments et des substances chimiques , Vitamine D/analogues et dérivés , Animaux , Lymphocytes T CD4+/immunologie , Lymphocytes T CD4+/métabolisme , Calcitriol/pharmacologie , Calcitriol/usage thérapeutique , Cellules cultivées , Méthylation de l'ADN/physiologie , Protéines de liaison à l'ADN/immunologie , Protéines de liaison à l'ADN/métabolisme , Encéphalomyélite auto-immune expérimentale/immunologie , Encéphalomyélite auto-immune expérimentale/métabolisme , Femelle , Facteurs de transcription Forkhead/immunologie , Facteurs de transcription Forkhead/métabolisme , Mâle , Méthionine/métabolisme , Souris , Souris de lignée C57BL , Souris transgéniques , Maladies neurodégénératives/traitement médicamenteux , Maladies neurodégénératives/immunologie , Maladies neurodégénératives/métabolisme , Lymphocytes T régulateurs/immunologie , Lymphocytes T régulateurs/métabolisme , Facteurs de transcription/immunologie , Facteurs de transcription/métabolisme , Vitamine D/pharmacologie , Vitamine D/usage thérapeutiqueRÉSUMÉ
Multiple sclerosis (MS) is a neurodegenerative disease resulting from an autoimmune attack on the axon-myelin unit. A female MS bias becomes evident after puberty and female incidence has tripled in the last half-century, implicating a female sex hormone interacting with a modifiable environmental factor. These aspects of MS suggest that many female MS cases may be preventable. Mechanistic knowledge of this hormone-environment interaction is needed to devise strategies to reduce female MS risk. We previously demonstrated that vitamin D3 (D3) deficiency increases and D3 supplementation decreases experimental autoimmune encephalomyelitis (EAE) risk in a female-biased manner. We also showed that D3 acts in an estrogen (E2)-dependent manner, since ovariectomy eliminated and E2 restored D3-mediated EAE protection. Here we probed the hypothesis that E2 and D3 interact synergistically within CD4(+) T cells to control T cell fate and prevent demyelinating disease. The E2 increased EAE resistance in wild-type (WT) but not T-Vdr(0) mice lacking Vdr gene function in CD4(+) T cells, so E2 action depended entirely on Vdr(+)CD4(+) T cells. The E2 levels were higher in WT than T-Vdr(0) mice, suggesting the Vdr(+)CD4(+) T cells produced E2 or stimulated its production. The E2 decreased Cyp24a1 and increased Vdr transcripts in T cells, prolonging the calcitriol half-life and increasing calcitriol responsiveness. The E2 also increased CD4(+)Helios(+)FoxP3(+) T regulatory (Treg) cells in a Vdr-dependent manner. Thus, CD4(+) T cells have a cooperative amplification loop involving E2 and calcitriol that promotes CD4(+)Helios(+)FoxP3(+) Treg cell development and is disrupted when the D3 pathway is impaired. The global decline in population D3 status may be undermining a similar cooperative E2-D3 interaction controlling Treg cell differentiation in women, causing a breakdown in T cell self tolerance and a rise in MS incidence.
Sujet(s)
Maladies auto-immunes du système nerveux/prévention et contrôle , Lymphocytes T CD4+/métabolisme , Protéines de liaison à l'ADN/métabolisme , Oestrogènes/administration et posologie , Facteurs de transcription Forkhead/métabolisme , Récepteur calcitriol/métabolisme , Lymphocytes T régulateurs/métabolisme , Facteurs de transcription/métabolisme , Vitamine D/administration et posologie , Animaux , Maladies auto-immunes du système nerveux/induit chimiquement , Maladies auto-immunes du système nerveux/génétique , Maladies auto-immunes du système nerveux/anatomopathologie , Lymphocytes T CD4+/effets des médicaments et des substances chimiques , Protéines de liaison à l'ADN/génétique , Modèles animaux de maladie humaine , Synergie des médicaments , Femelle , Facteurs de transcription Forkhead/génétique , Régulation de l'expression des gènes au cours du développement/effets des médicaments et des substances chimiques , Régulation de l'expression des gènes au cours du développement/génétique , Techniques in vitro , Mâle , Souris , Souris de lignée C57BL , Souris transgéniques , Glycoprotéine MOG/toxicité , Ovariectomie , Fragments peptidiques/toxicité , Grossesse , Récepteur calcitriol/génétique , Lymphocytes T régulateurs/effets des médicaments et des substances chimiques , Facteurs temps , Facteurs de transcription/génétique , Utérus/anatomopathologieRÉSUMÉ
This review summarizes and integrates research on vitamin D and CD4(+) T-lymphocyte biology to develop new mechanistic insights into the molecular etiology of autoimmune disease. A deep understanding of molecular mechanisms relevant to gene-environment interactions is needed to deliver etiology-based autoimmune disease prevention and treatment strategies. Evidence linking sunlight, vitamin D, and the risk of multiple sclerosis and type 1 diabetes is summarized to develop the thesis that vitamin D is the environmental factor that most strongly influences autoimmune disease development. Evidence for CD4(+) T-cell involvement in autoimmune disease pathogenesis and for paracrine calcitriol signaling to CD4(+) T lymphocytes is summarized to support the thesis that calcitriol is sunlight's main protective signal transducer in autoimmune disease risk. Animal modeling and human mechanistic data are summarized to support the view that vitamin D probably influences thymic negative selection, effector Th1 and Th17 pathogenesis and responsiveness to extrinsic cell death signals, FoxP3(+)CD4(+) T-regulatory cell and CD4(+) T-regulatory cell type 1 (Tr1) cell functions, and a Th1-Tr1 switch. The proposed Th1-Tr1 switch appears to bridge two stable, self-reinforcing immune states, pro- and anti-inflammatory, each with a characteristic gene regulatory network. The bi-stable switch would enable T cells to integrate signals from pathogens, hormones, cell-cell interactions, and soluble mediators and respond in a biologically appropriate manner. Finally, unanswered questions and potentially informative future research directions are highlighted to speed delivery of etiology-based strategies to reduce autoimmune disease.
RÉSUMÉ
Multiple sclerosis (MS) is an incurable inflammatory demyelinating disease. We investigated one calcitriol dose plus vitamin D3 (calcitriol/+D) as a demyelinating disease treatment in experimental autoimmune encephalomyelitis (EAE). Evidence that calcitriol-vitamin D receptor pathway deficits may promote MS, and data showing calcitriol enhancement of autoimmune T cell apoptosis provided the rationale. Whereas vitamin D3 alone was ineffective, calcitriol/+D transiently increased central nervous system (CNS) Helios(+)FoxP3(+) T cells and sustainably decreased CNS T cells, pathology, and neurological deficits in mice with EAE. Calcitriol/+D, which was more effective than methylprednisolone, has potential for reversing inflammatory demyelinating disease safely and cost-effectively.
Sujet(s)
Calcitriol/administration et posologie , Protéines de liaison à l'ADN/biosynthèse , Encéphalomyélite auto-immune expérimentale/traitement médicamenteux , Encéphalomyélite auto-immune expérimentale/métabolisme , Facteurs de transcription Forkhead/biosynthèse , Sous-populations de lymphocytes T/immunologie , Sous-populations de lymphocytes T/métabolisme , Facteurs de transcription/biosynthèse , Régulation positive/immunologie , Animaux , Bovins , Encéphalomyélite auto-immune expérimentale/anatomopathologie , Femelle , Numération des lymphocytes , Mâle , Souris , Répartition aléatoire , Sous-populations de lymphocytes T/effets des médicaments et des substances chimiques , Régulation positive/effets des médicaments et des substances chimiquesRÉSUMÉ
Compelling evidence suggests that vitamin D3 insufficiency may contribute causally to multiple sclerosis (MS) risk. Experimental autoimmune encephalomyelitis (EAE) research firmly supports this hypothesis. Vitamin D3 supports 1,25-dihydroxyvitamin D3 (1,25-[OH]2D3) synthesis in the CNS, initiating biological processes that reduce pathogenic CD4+ T cell longevity. MS is prevalent in Sardinia despite high ambient UV irradiation, challenging the vitamin D-MS hypothesis. Sardinian MS patients frequently carry a low Ifng expresser allele, suggesting that inadequate IFN-γ may undermine vitamin D3-mediated inhibition of demyelinating disease. Testing this hypothesis, we found vitamin D3 failed to inhibit EAE in female Ifng knockout (GKO) mice, unlike wild-type mice. The two strains did not differ in Cyp27b1 and Cyp24a1 gene expression, implying equivalent vitamin D3 metabolism in the CNS. The 1,25-(OH)2D3 inhibited EAE in both strains, but 2-fold more 1,25-(OH)2D3 was needed in GKO mice, causing hypercalcemic toxicity. Unexpectedly, GKO mice had very low Vdr gene expression in the CNS. Injecting IFN-γ intracranially into adult mice did not increase Vdr gene expression. Correlating with low Vdr expression, GKO mice had more numerous pathogenic Th1 and Th17 cells in the CNS, and 1,25-(OH)2D3 reduced these cells in GKO and wild-type mice without altering Foxp3+ regulatory T cells. Thus, the Ifng gene was needed for CNS Vdr gene expression and vitamin D3-dependent mechanisms that inhibit EAE. Individuals with inadequate Ifng expression may have increased MS risk despite high ambient UV irradiation because of low Vdr gene expression and a high encephalitogenic T cell burden in the CNS.
Sujet(s)
Calcitriol/physiologie , Encéphalomyélite auto-immune expérimentale/immunologie , Régulation de l'expression des gènes/immunologie , Interféron gamma/physiologie , Hyperlymphocytose/prévention et contrôle , Sclérose en plaques/immunologie , Récepteur calcitriol/génétique , Sous-populations de lymphocytes T/immunologie , Animaux , Calcitriol/génétique , Modèles animaux de maladie humaine , Évolution de la maladie , Encéphalomyélite auto-immune expérimentale/étiologie , Encéphalomyélite auto-immune expérimentale/anatomopathologie , Femelle , Interféron gamma/biosynthèse , Interféron gamma/déficit , Hyperlymphocytose/immunologie , Hyperlymphocytose/anatomopathologie , Mâle , Souris , Souris de lignée C57BL , Souris knockout , Sclérose en plaques/étiologie , Sclérose en plaques/anatomopathologie , Récepteur calcitriol/biosynthèse , Facteurs de risque , Sous-populations de lymphocytes T/métabolisme , Sous-populations de lymphocytes T/anatomopathologieRÉSUMÉ
Multiple sclerosis (MS) is an autoimmune, neurodegenerative disease with a rapidly increasing female gender bias. MS prevalence decreases with increasing sunlight exposure, supporting our hypothesis that the sunlight-dependent hormone 1,25-dihydroxyvitamin D(3) (1,25-(OH)(2)D(3)) is a natural inhibitor of autoimmune T cell responses in MS. We found that vitamin D(3) inhibited experimental autoimmune encephalomyelitis (EAE) in intact female mice, but not in ovariectomized females or males. To learn whether 17beta-estradiol (E(2)) is essential for vitamin D(3)-mediated protection, ovariectomized female mice were given E(2) or placebo and evaluated for vitamin D(3)-mediated EAE resistance. Diestrus-level E(2) implants alone provided no benefit, but they restored vitamin D(3)-mediated EAE resistance in the ovariectomized females. Synergy between E(2) and vitamin D(3) occurred through vitamin D(3)-mediated enhancement of E(2) synthesis, as well as E(2)-mediated enhancement of vitamin D receptor expression in the inflamed CNS. In males, E(2) implants did not enable vitamin D(3) to inhibit EAE. The finding that vitamin D(3)-mediated protection in EAE is female-specific and E(2)-dependent suggests that declining vitamin D(3) supplies due to sun avoidance might be contributing to the rapidly increasing female gender bias in MS. Moreover, declining E(2) synthesis and vitamin D(3)-mediated protection with increasing age might be contributing to MS disease progression in older women.
Sujet(s)
Cholécalciférol/métabolisme , Encéphalomyélite auto-immune expérimentale/étiologie , Oestradiol/physiologie , Récepteur calcitriol/biosynthèse , Animaux , Système nerveux central/métabolisme , Oestradiol/biosynthèse , Oestradiol/pharmacologie , Oestrogènes , Femelle , Humains , Mâle , Souris , Ovariectomie , Facteurs sexuels , VitaminesRÉSUMÉ
Systemic lupus erythematosus pathology reflects autoantibody-mediated damage due to a failure of B-lymphocyte tolerance. We previously reported that B-lymphopenic A/WySnJ mice develop a lupus-like syndrome and linked this syndrome to the B-cell maturation defect-1 (Bcmd-1) mutant allele of the B-cell-activating factor belonging to the TNF family-receptor (Baffr) gene. Here, we further evaluate the genetic basis for autoimmunity in A/WySnJ mice. We produced B6.Bcmd-1 and AW.Baffr(-/-) congenic mice (N5), and compared them with B6.Baffr(-/-) and A/WySnJ mice with respect to B-lymphocyte development. Bcmd-1-expressing mice had more B cells with greater maturity than Baffr(-/-) mice regardless of genetic background, indicating that Bcmd-1 encodes a partially functional BAFF-R. We also compared these mice for lupus phenotypes to determine whether Bcmd-1 is necessary and sufficient for disease, or whether the Baffr(-/-) (-) allele can also cause autoimmunity. The Baffr(-/-) allele did not lead to autoimmunity on either genetic background. In contrast, the Bcmd-1 allele was necessary and sufficient for development of low levels of IgM autoantibodies in B6.Bcmd-1 mice. However, Bcmd-1 plus unidentified A/WySnJ modifier genes were necessary for development of IgG autoantibodies and renal pathology. We propose that in A/WySnJ mice an excess of BAFF per B cell rescues self-reactive B cells through a partially functional BAFF-R in a B-lymphopenic environment.
Sujet(s)
Auto-immunité/immunologie , Facteur d'activation des lymphocytes B/immunologie , Récepteur du BAFF/immunologie , Lymphocytes B/immunologie , Lupus érythémateux disséminé/immunologie , Allèles , Séquence d'acides aminés , Animaux , Autoanticorps/sang , Auto-immunité/génétique , Facteur d'activation des lymphocytes B/génétique , Récepteur du BAFF/génétique , Lymphocytes B/métabolisme , Lupus érythémateux disséminé/génétique , Souris , Souris congéniques , Souris knockout , Données de séquences moléculaires , Alignement de séquences , Transduction du signal/génétique , Transduction du signal/immunologieRÉSUMÉ
Systemic lupus erythematosis is an autoimmune disease of unknown etiology. Lupus pathology is thought to reflect autoantibody-mediated damage due to a failure of B lymphocyte tolerance. Since excessive B cell-activating factor belonging to the TNF family (BAFF) expression correlates with human and murine lupus, and BAFF signals B cell survival through BAFF-R, it is believed that excessive BAFF-R signaling can subvert B cell tolerance and facilitate lupus development. Here we report the unexpected finding that BAFF-R-mutant A/WySnJ mice develop a lupus-like syndrome. These mice carry the B cell maturation defect-1 (Bcmd-1) mutant allele of the Baffr gene. Bcmd-1 causes premature B cell death and profound B cell deficiency. Despite having 90% fewer splenic B cells than normal mice, A/WySnJ mice had an 18-fold increased frequency of splenocytes secreting IgM antibodies to dsDNA, and increased amounts of circulating IgM and IgG to dsDNA by 9 months of age. By age 11 months, most A/WySnJ mice displayed renal pathology characteristic of lupus, including proteinuria as well as periodic acid-Schiff-positive deposits and glomerular capillary bed destruction. Importantly, we genetically linked this autoimmunity to Bcmd-1, since congenic AW.Baffr(+/+) mice carrying a wild-type allele developed none of these phenotypes. Our data provide the first evidence linking altered BAFF-R signaling to the development of B cell-mediated autoimmunity.
Sujet(s)
Maladies auto-immunes/génétique , Mutation , Animaux , Autoanticorps/biosynthèse , Autoanticorps/sang , Maladies auto-immunes/métabolisme , Maladies auto-immunes/anatomopathologie , Facteur d'activation des lymphocytes B/métabolisme , Récepteur du BAFF/génétique , Lymphocytes B/immunologie , Chromatine/immunologie , Femelle , Humains , Rein/immunologie , Rein/anatomopathologie , Mâle , Souris , Souris de lignée A , Souches mutantes de souris , Chimère post-radique/immunologie , Transduction du signal/génétique , Transduction du signal/immunologieRÉSUMÉ
Multiple sclerosis (MS) is a complex neurodegenerative disease whose pathogenesis involves genetic and environmental risk factors leading to an aberrant, neuroantigen-specific, CD4+ T cell-mediated autoimmune response. In support of the hypothesis that vitamin D3 may reduce MS risk and severity, we found that vitamin D3 and 1,25-dihydroxyvitamin D3 (1,25-(OH)2D3) inhibited induction of experimental autoimmune encephalomyelitis (EAE), an MS model. To investigate how 1,25-(OH)2D3 could carry out anti-inflammatory functions, we administered 1,25-(OH)2D3 or a placebo to mice with EAE, and subsequently analyzed clinical disease, chemokines, inducible nitric oxide synthase (iNOS), and recruitment of dye-labeled monocytes. The 1,25-(OH)2D3 treatment significantly reduced clinical EAE severity within 3 days. Sharp declines in chemokines, inducible iNOS, and CD11b+ monocyte recruitment into the central nervous system (CNS) preceded this clinical disease abatement in the 1,25-(OH)2D3-treated animals. The 1,25-(OH)2D3 did not directly and rapidly inhibit chemokine synthesis in vivo or in vitro. Rather, the 1,25-(OH)2D3 rapidly stimulated activated CD4+ T cell apoptosis in the CNS and spleen. Collectively, these results support a model wherein inflammation stimulates a natural anti-inflammatory feedback loop. The activated inflammatory cells produce 1,25-(OH)2D3, and this hormone subsequently enhances the apoptotic death of inflammatory CD4+ T cells, removing the driving force for continued inflammation. In this way, the sunlight-derived hormone could reduce the risk of chronic CNS inflammation and autoimmune-mediated neurodegenerative disease.
Sujet(s)
Calcitriol/pharmacologie , Chimiokines/biosynthèse , Chimiotaxie des leucocytes/effets des médicaments et des substances chimiques , Encéphalomyélite auto-immune expérimentale/traitement médicamenteux , Monocytes/effets des médicaments et des substances chimiques , Neuroprotecteurs/pharmacologie , Animaux , Apoptose/effets des médicaments et des substances chimiques , Apoptose/immunologie , Encéphalomyélite auto-immune expérimentale/immunologie , Immunohistochimie , Souris , Monocytes/métabolisme , Monoxyde d'azote/métabolisme , Nitric oxide synthase type II/effets des médicaments et des substances chimiques , Nitric oxide synthase type II/métabolisme , RT-PCR , Lymphocytes auxiliaires Th1/effets des médicaments et des substances chimiques , Lymphocytes auxiliaires Th1/immunologie , Vitamines/pharmacologieRÉSUMÉ
Multiple sclerosis (MS) results from an aberrant, neuroantigen-specific, T cell-mediated autoimmune response. Because MS prevalence and severity decrease sharply with increasing sunlight exposure, and sunlight supports vitamin D(3) synthesis, we proposed that vitamin D(3) and 1,25-dihydroxyvitamin D(3) (1,25-(OH)(2)D(3)) may protect against MS. In support of this hypothesis, 1,25-(OH)(2)D(3) strongly inhibited experimental autoimmune encephalomyelitis (EAE). This inhibition required lymphocytes other than the encephalitogenic T cells. In this study, we tested the hypothesis that 1,25-(OH)(2)D(3) might inhibit EAE through the action of IL-10-producing regulatory lymphocytes. We report that vitamin D(3) and 1,25-(OH)(2)D(3) strongly inhibited myelin oligodendrocyte peptide (MOG(35-55))-induced EAE in C57BL/6 mice, but completely failed to inhibit EAE in mice with a disrupted IL-10 or IL-10R gene. Thus, a functional IL-10-IL-10R pathway was essential for 1,25-(OH)(2)D(3) to inhibit EAE. The 1,25-(OH)(2)D(3) also failed to inhibit EAE in reciprocal, mixed bone marrow chimeras constructed by transferring IL-10-deficient bone marrow into irradiated wild-type mice and vice versa. Thus, 1,25-(OH)(2)D(3) may be enhancing an anti-inflammatory loop involving hemopoietic cell-produced IL-10 acting on brain parenchymal cells and vice versa. If this interpretation is correct, and humans have a similar bidirectional IL-10-dependent loop, then an IL-10-IL-10R pathway defect could abrogate the anti-inflammatory and neuro-protective functions of sunlight and vitamin D(3). In this way, a genetic IL-10-IL-10R pathway defect could interact with an environmental risk factor, vitamin D(3) insufficiency, to increase MS risk and severity.
Sujet(s)
Calcitriol/administration et posologie , Encéphalomyélite auto-immune expérimentale/prévention et contrôle , Interleukine-10/métabolisme , Récepteurs à l'interleukine-10/métabolisme , Lymphocytes T régulateurs/immunologie , Animaux , Cellules de la moelle osseuse/effets des médicaments et des substances chimiques , Cellules de la moelle osseuse/immunologie , Chimère/immunologie , Encéphalomyélite auto-immune expérimentale/immunologie , Encéphalomyélite auto-immune expérimentale/anatomopathologie , Glycoprotéines/antagonistes et inhibiteurs , Interleukine-10/génétique , Souris , Souches mutantes de souris , Glycoprotéine MOG , Fragments peptidiques/antagonistes et inhibiteurs , Récepteurs à l'interleukine-10/génétique , Transduction du signal/génétique , Transduction du signal/immunologieRÉSUMÉ
Multiple sclerosis (MS) is a debilitating autoimmune disease of the central nervous system (CNS) that develops in genetically susceptible individuals who are exposed to undefined environmental risk factors. Epidemiological, genetic, and biological evidence suggests that insufficient vitamin D may be an MS risk factor. However, little is known about how vitamin D might be protective in MS. We hypothesized that 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3] might regulate gene expression patterns in a manner that would resolve inflammation. To test this hypothesis, experimental autoimmune encephalomyelitis (EAE) was induced in mice, 1,25-(OH)2D3 or a placebo was administered, and 6 h later, DNA microarray hybridization was performed with spinal cord RNA to analyze the gene expression patterns. At this time, clinical, histopathological, and biological studies showed that the two groups did not differ in EAE disease, but changes in several 1,25-(OH)2D3-responsive genes indicated that the 1,25-(OH)2D3 had reached the CNS. Compared with normal mice, placebo-treated mice with EAE showed increased expression of many immune system genes, confirming the acute inflammation. When 1,25-(OH)2D3 was administered, several genes like glial fibrillary acidic protein and eukaryotic initiation factor 2alpha kinase 4, whose expression increased or decreased with EAE, returned to homeostatic levels. Also, two genes with pro-apoptotic functions, calpain-2 and caspase-8-associated protein, increased significantly. A terminal deoxynucleotidyl transferase-mediated dUTP nicked end labeling study detected increased nuclear fragmentation in the 1,25-(OH)2D3-treated samples, confirming increased apoptosis. Together, these results suggest that sensitization of inflammatory cells to apoptotic signals may be one mechanism by which the 1,25-(OH)2D3 resolved EAE.
Sujet(s)
Apoptose/physiologie , Encéphalomyélite auto-immune expérimentale/métabolisme , Analyse de profil d'expression de gènes/méthodes , Régulation de l'expression des gènes/physiologie , Vitamine D/analogues et dérivés , Vitamine D/physiologie , Animaux , Astrocytes/composition chimique , Astrocytes/métabolisme , Lymphocytes T CD4+/composition chimique , Lymphocytes T CD4+/métabolisme , Système nerveux central/composition chimique , Système nerveux central/métabolisme , Système nerveux central/anatomopathologie , Modèles animaux de maladie humaine , Encéphalomyélite auto-immune expérimentale/génétique , Encéphalomyélite auto-immune expérimentale/anatomopathologie , Régulation de l'expression des gènes/génétique , Lymphocytes/composition chimique , Lymphocytes/métabolisme , Lymphocytes/physiologie , Macrophages/composition chimique , Macrophages/métabolisme , Macrophages/physiologie , Mâle , Souris , Souris de lignée C57BL , Moelle spinale/anatomopathologie , Sous-populations de lymphocytes T/composition chimique , Sous-populations de lymphocytes T/métabolismeRÉSUMÉ
Previously we reported that vitamin A-deficient (-A) mice had a profound reduction in T helper 2 (Th2) cells, accounting for their depressed T-dependent antibody responses. Providing vitamin A or its active metabolites reversed this defect. The current experiments utilized splenocytes from T cell receptor transgenic mice to investigate how all-trans retinoic acid (atRA) augments Th2 development. These cells were stimulated in vitro in the presence or absence of atRA, with or without exogenous cytokines driving Th1 or Th2 development. Without exogenous cytokines, atRA addition significantly inhibited the interferon (IFN)-gamma response but did not alter the interleukin (IL)-4 response. With Th1 polarizing cytokines, atRA enhanced the IFN-gamma response, with no effect on the IL-4 response. Most importantly, with the Th2 polarizing cytokine IL-4, atRA significantly increased the IL-4 secretion (fivefold) and also increased the Th2 cell frequency twofold. The striking Th2 enhancement was also observed when only antigen-presenting cells were treated with atRA before stimulation of untreated CD4(+) transgenic T cells, but not vice versa. Thus, atRA maximized Th2 cell development in an IL-4-dependent manner, through an effect on antigen-presenting cell function.